[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625977":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":18,"responsibleParty":38,"collaborators":18,"id":42,"slug":18,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":18,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":18,"studyType":54,"phases":55,"briefSummary":58,"conditions":59,"keywords":18,"overallStatus":61,"whyStopped":18,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":18},{"fullName":5,"class":6},"Assiut University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm A","EXPERIMENTAL","endoscopic ultrasound local chemotherapeutic drug injection in addition to systemic chemotherapy",[13],"Drug: endoscopic ultrasonograhy guided chemptherapy injection",{"label":15,"type":16,"description":17,"interventionNames":18},"B","NO_INTERVENTION","patients who recieve chemotherapeutic drug only",null,[20],{"type":21,"name":22,"description":22,"armGroupLabels":23,"otherNames":18},"DRUG","endoscopic ultrasonograhy guided chemptherapy injection",[9],[25],{"name":26,"affiliation":5,"role":27},"laila abd baqi tony, professor","STUDY_CHAIR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Al shaimaa Eid Abd El Tawab, Assisstant lecturer","CONTACT","201065803070","alshaimaaeid1995@yahoo.com",{"name":35,"role":31,"phone":36,"phoneExt":18,"email":37},"islam mohamed Abd El-Hameed, assisstant lecturer","201016329653","islammohamed846@yahoo.com",{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Alshaimaa Eid","assiut city- assiut university street","100625977",false,"NCT07429643","Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.","Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer: A Randomized Controlled Trial.","Inclusion Criteria:\n\n* Age \\> 18 years old.\n* Patients recently diagnosed to have pancreatic adenocarcinoma based on histopathological examination.\n* Locally advanced potentially resectable pancreatic cancer . .Eastern Cooperative Oncology Group performance status of 0 to 1. .Signed informed consent.\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years old.\n* Metastatic pancreatic cancer.\n* prior pancreatic surgery or chemotherapy or radiotherapy. concurrent or prior malignancy. coexistent medical condition precluding protocol therapy.","ALL","18 Years","60 Years",{"count":52,"type":53},20,"ESTIMATED","INTERVENTIONAL",[56,57],"PHASE2","PHASE3","this is a randomized controlled trial aims to compare between patients with locally advanced pancreatic cancer treated with EUS-guided injection of gemcitabine in addition to systemic chemotherapy, versus those who treated with the standard systemic chemotherapy alone, regarding to(progression -free survival and response rate).\n\nResearchers will compare Arm A: patients received EUS-FNI of gemcitabine plus standard systemic chemotherapy to Arm B : patients receiving the standard systemic chemotherapy alone.",[60],"Locally Advanced Pancreatic Cancer","NOT_YET_RECRUITING","2026-02-20",{"date":64,"type":65},"2026-02-24","ACTUAL",{"date":67,"type":53},"2026-04-15",{"date":69,"type":53},"2028-12-30",{"name":5,"class":6}]